BRCA1 loss activates cathepsin L–mediated degradation of 53BP1 in breast cancer cells
Grotsky, David A.
Novell Álvarez, Anna
Yaddanapudi, Sree C.
Redwood, Abena B.
Ramon y Cajal, Teresa
Dusso Rosso, Adriana
MetadataShow full item record
Loss of 53BP1 rescues BRCA1 deficiency and is associated with BRCA1-deficient and triple-negative breast cancers (TNBC) and with resistance to genotoxic drugs. The mechanisms responsible for decreased 53BP1 transcript and protein levels in tumors remain unknown. Here, we demonstrate that BRCA1
loss activates cathepsin L (CTSL)–mediated degradation of 53BP1. Activation of this pathway rescued homologous recombination repair and allowed BRCA1-deficient cells to bypass growth arrest. Importantly, depletion or inhibition of CTSL with vitamin D or specific inhibitors stabilized 53BP1 and increased genomic instability in response to radiation and poly(adenosine diphosphate–ribose) polymerase inhibitors, compromising proliferation. Analysis of human breast tumors identified nuclear CTSL as a positive biomarker for TNBC, which correlated inversely with 53BP1. Importantly, nuclear levels of CTSL, vitamin D receptor, and 53BP1 emerged as a novel triple biomarker signature for stratification of patients with BRCA1-mutated tumors and TNBC, with potential predictive value for drug response. We identify here a novel pathway with prospective relevance for diagnosis and customization of breast cancer therapy.
Is part ofJournal of Cell Biology, 2005, vol. 200, núm. 2, p. 187-202
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as cc-by-nc-sa, (c) Grotsky et al., 2013
Showing items related by title, author, creator and subject.
The effect on quality of life of vitamin d administration for advanced cancer treatment (vidafact study): Protocol of a randomised controlled trial Martínez Alonso, Montserrat; Ariza Carrió, Gemma; Dusso Rosso, Adriana; Nabal Vicuña, Maria (BMJ Publishing Group, 2015)Introduction: Vitamin D is related to resistance to chronic diseases, physiological parameters and functional measures. All of these relationships underscore the potential benefits of cholecalciferol or D3 (nutritional ...
Barley-ß-glucans reduce systemic inflammation, renal injury and aortic calcification through ADAM17 and neutral-sphingomyelinase2 inhibition Arcidiacono, Maria V.; Carrillo-López, Natalia; Panizo García, Sara; Castro-Grattoni, Anabel L.; Valcheva, Petya; Ulloa, Catalina; Rodríguez-Carrio, Javier; Cardús i Figueras, Anna; Quirós-Caso, Covadonga; Martínez-Arias, Laura; Martínez-Salgado, Carlos; Motilva Casado, Mª José; Rodríguez Suárez, Carmen; Cannata-Andía, Jorge B.; Dusso Rosso, Adriana (Springer Nature, 2019-11-28)In chronic kidney disease (CKD), hyperphosphatemia-induced inflammation aggravates vascular calcification (VC) by increasing vascular smooth muscle cell (VSMC) osteogenic differentiation, ADAM17-induced renal and vascular ...
2-phenylethynesulphonamide (PFT-μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels Yeramian Hakim, Andree; Veà Jódar, Àlvar; Benítez, Sandra; Ribera i Calvet, Joan; Domingo, Mónica; Santacana Espasa, Maria; Martínez Alonso, Montserrat; Maiques Carlos, Oscar; Valls Marsal, Joan; Dolcet Roca, Xavier; Vilella, Ramón; Cabiscol Català, Elisa; Matias-Guiu, Xavier; Marti, Rosa M. (Wiley online library, 2016)Heat shock proteins (HSPs), are molecular chaperones that assist the proper folding of nascent proteins. This study aims to evaluate the antitumour effects of the hsp90 inhibitor NVP-AUY922 in melanoma, both in vitro ...